Literature DB >> 17727667

Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation.

Michael Wong1.   

Abstract

Malformations of cortical development (MCDs) are increasingly recognized as causes of medically intractable epilepsy. In order to develop more effective, rational therapies for refractory epilepsy related to MCDs, it is important to achieve a better understanding of the underlying mechanisms of epileptogenesis, but this is complicated by the wide variety of different radiographic, histopathological, and molecular features of these disorders. A subset of MCDs share a number of characteristic cellular and molecular abnormalities due to early defects in neuronal and glial proliferation and differentiation and have a particularly high incidence of epilepsy, suggesting that this category of MCDs with abnormal glioneuronal proliferation may also share a common set of primary mechanisms of epileptogenesis. This review critically analyzes both clinical and basic science evidence for overlapping mechanisms of epileptogenesis in this group of disorders, focusing on tuberous sclerosis complex, focal cortical dysplasia with balloon cells, and gangliogliomas. Specifically, the role of lesional versus perilesional regions, circuit versus cellular/molecular defects, and nonneuronal factors, such as astrocytes, in contributing to epileptogenesis in these MCDs is examined. An improved understanding of these various factors involved in epileptogenesis has direct clinical implications for optimizing current treatments or developing novel therapeutic approaches for epilepsy in these disorders.

Entities:  

Mesh:

Year:  2007        PMID: 17727667      PMCID: PMC3934641          DOI: 10.1111/j.1528-1167.2007.01270.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  95 in total

Review 1.  GLIA: listening and talking to the synapse.

Authors:  P G Haydon
Journal:  Nat Rev Neurosci       Date:  2001-03       Impact factor: 34.870

2.  Mutational analysis of TSC1 and TSC2 genes in gangliogliomas.

Authors:  A J Becker; M Löbach; H Klein; S Normann; M M Nöthen; A von Deimling; M Mizuguchi; C E Elger; J Schramm; O D Wiestler; I Blümcke
Journal:  Neuropathol Appl Neurobiol       Date:  2001-04       Impact factor: 8.090

3.  Epilepsy surgery in children with tuberous sclerosis complex: presurgical evaluation and outcome.

Authors:  S Koh; P Jayakar; C Dunoyer; S E Whiting; T J Resnick; L A Alvarez; G Morrison; J Ragheb; A Prats; P Dean; J Gilman; M S Duchowny
Journal:  Epilepsia       Date:  2000-09       Impact factor: 5.864

4.  Glioneuronal tumors and medically intractable epilepsy: a clinical study with long-term follow-up of seizure outcome after surgery.

Authors:  E Aronica; S Leenstra; C W van Veelen; P C van Rijen; T J Hulsebos; A C Tersmette; B Yankaya; D Troost
Journal:  Epilepsy Res       Date:  2001-03       Impact factor: 3.045

5.  Reduced inhibition in an animal model of cortical dysplasia.

Authors:  W J Zhu; S N Roper
Journal:  J Neurosci       Date:  2000-12-01       Impact factor: 6.167

6.  Differential expression of glutamate and GABA-A receptor subunit mRNA in cortical dysplasia.

Authors:  P B Crino; A C Duhaime; G Baltuch; R White
Journal:  Neurology       Date:  2001-04-10       Impact factor: 9.910

7.  Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers.

Authors:  R White; Y Hua; B Scheithauer; D R Lynch; E P Henske; P B Crino
Journal:  Ann Neurol       Date:  2001-01       Impact factor: 10.422

8.  Ionotropic and metabotropic glutamate receptor protein expression in glioneuronal tumours from patients with intractable epilepsy.

Authors:  E Aronica; B Yankaya; G H Jansen; S Leenstra; C W van Veelen; J A Gorter; D Troost
Journal:  Neuropathol Appl Neurobiol       Date:  2001-06       Impact factor: 8.090

Review 9.  Molecular genetic classification of central nervous system malformations.

Authors:  H B Sarnat
Journal:  J Child Neurol       Date:  2000-10       Impact factor: 1.987

10.  Source localization and possible causes of interictal epileptic activity in tumor-associated epilepsy.

Authors:  S Patt; J Steenbeck; A Hochstetter; R Kraft; R Huonker; J Haueisen; N Haberland; K Ebmeier; R Hliscs; J Fiehler; H Nowak; R Kalff
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

View more
  59 in total

1.  Tuber-Less Models of Tuberous Sclerosis Still Provide Insights Into Epilepsy.

Authors:  Michael Wong
Journal:  Epilepsy Curr       Date:  2015 May-Jun       Impact factor: 7.500

Review 2.  mTOR signaling in epilepsy: insights from malformations of cortical development.

Authors:  Peter B Crino
Journal:  Cold Spring Harb Perspect Med       Date:  2015-04-01       Impact factor: 6.915

Review 3.  Epilepsy secondary to tuberous sclerosis: lessons learned and current challenges.

Authors:  Romina Moavero; Caterina Cerminara; Paolo Curatolo
Journal:  Childs Nerv Syst       Date:  2010-04-01       Impact factor: 1.475

Review 4.  Mammalian target of rapamycin (mTOR) activation in focal cortical dysplasia and related focal cortical malformations.

Authors:  Michael Wong
Journal:  Exp Neurol       Date:  2011-10-08       Impact factor: 5.330

5.  Bayesian network and mechanistic hierarchical structure modeling of increased likelihood of developing intractable childhood epilepsy from the combined effect of mtDNA variants, oxidative damage, and copy number.

Authors:  Brenda Luna; Sanjiv Bhatia; Changwon Yoo; Quentin Felty; David I Sandberg; Michael Duchowny; Ziad Khatib; Ian Miller; John Ragheb; Jayakar Prasanna; Deodutta Roy
Journal:  J Mol Neurosci       Date:  2014-07-16       Impact factor: 3.444

6.  Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.

Authors:  Bo Zhang; Jia Zou; Nicholas R Rensing; Meihua Yang; Michael Wong
Journal:  Neurobiol Dis       Date:  2015-05-21       Impact factor: 5.996

7.  The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.

Authors:  Bo Zhang; Jia Zou; Lirong Han; Brennan Beeler; Joseph L Friedman; Elizabeth Griffin; Yue-Shan Piao; Nicholas R Rensing; Michael Wong
Journal:  Epilepsia       Date:  2018-08-05       Impact factor: 5.864

Review 8.  Genetic animal models of malformations of cortical development and epilepsy.

Authors:  Michael Wong; Steven N Roper
Journal:  J Neurosci Methods       Date:  2015-04-21       Impact factor: 2.390

9.  Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.

Authors:  Ling-Hui Zeng; Lin Xu; David H Gutmann; Michael Wong
Journal:  Ann Neurol       Date:  2008-04       Impact factor: 10.422

10.  Expression Patterns of TRPC1 in Cortical Lesions from Patients with Focal Cortical Dysplasia.

Authors:  Zhenle Zang; Song Li; Wei Zhang; Xin Chen; Dahai Zheng; Haifeng Shu; Wei Guo; Bangyun Zhao; Kaifeng Shen; YuJia Wei; Xin Zheng; Shiyong Liu; Hui Yang
Journal:  J Mol Neurosci       Date:  2015-08-18       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.